Clinical Trial Update: Peptide Vaccination in Treating Patients With Esophageal Cancer (STF-II) [Phase 2]

View source ↗

Summary

This document notes an ongoing Phase 2 clinical trial (STF-II) evaluating a peptide vaccine in patients with esophageal cancer. The current status is listed as …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Esophageal Cancer

Drugs mentioned

• STF-II peptide vaccine

Snippet

Sponsor: University of Yamanashi | Conditions: Esophageal Cancer | Phase 2 | Status: UNKNOWN